adecatumumab recombinant human monoclonal antibody used target tumor cells binds epithelial cell adhesion molecule epcam intent trigger antibodydependent cellular cytotoxicity developed micromet inc acquired adecatumumab used clinical studies treatment colorectal breast phase ii results published monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikiadecatumumab